Since February 1, 1980, 515 morbidly obese patients have undergone the Greenville gastric bypass (GGB) operation. Of these, 212 (41.2%) were euglycemic, 288 (55.9%) were either diabetic or had glucose intolerance, and 15 (2.9%) were unable to complete the evaluation. After the operation, only 30 (5.8%) patients remained diabetic (and 20 of these improved), 457 (88.7%) became and have remained euglycemic, and inadequate data prevented classification of the other 28 (5.4%). The patients who failed to return to normal glucose values were older and their diabetes was of longer duration than those who did. The effect of the GGB was not only limited to the correction of abnormal glucose levels. The GGB also corrected the abnormal levels of fasting insulin and glycosylated hemoglobin in a cohort of 52 consecutive severely obese patients with non-insulin-dependent diabetes. The GGB effectively controls weight. If morbid obesity is defined as 100 pounds over ideal body weight, 89% of the patients are no longer "morbidly" obese within 2 years. In most patients, the control of the weight has been well maintained during the 11 years of follow-up; most of the upward creep in weight of 20.8% between 24 and 132 months was from the 49 (9.5%) patients who had staple line breakdowns between the large and small gastric pouches. Non-insulin-dependent diabetes, previously considered a chronic unrelenting disease, can be controlled in the severely obese by the gastric bypass. Whether the correction of glucose metabolism affects the complications of diabetes is unknown. Whether the gastric bypass should be considered for patients with advanced non-insulin-dependent diabetes but who are not severely obese deserves consideration. The GGB has an unacceptably high rate of staple line failure. Accordingly, the authors have recently changed their procedure to one that divides the stomach rather than partitions it with staples.
D A IABETES MELLITUS IS one of our most serious diseases. It accelerates the development of atherosclerosis, doubles the risk for stroke, and increases the risk of heart attacks twofold to threefold. Through its damage to the microvasculature, diabetes produces retinopathies, blindness, nephropathy, and neuropathy. In addition, there are broader systemic effects, such as the lessening of resistance to infection. The economic impact of the disease is enormous; in 1985 it was estimated to be $4 billion and may well be twice that high given the inflation in health care costs. Although the exact prevalence is unknown, the usual estimate is that 10 million Americans have the disease and, ofthese, 1.25 million take insulin, 1 to 1.5 million are on oral antidiabetic agents, and another two to three million are being managed by diet alone. Many remain undiagnosed. The disease is generally classified into two groups: type I diabetes or insulin-dependent diabetes, which afflicts about 200,000 to 300,000, and the far more common type II diabetes or non-insulin-dependent diabetes mellitus (NIDDM), which accounts for more than 95% of the cases. ' The basis for the current treatment of NIDDM is the maintenance of euglycemia and normal insulin levels. This "control of the diabetes" is considered the best approach to prevent the acute and chronic complications of diabetes and to ameliorate those changes that are already present. 2 Unfortunately, euglycemia cannot be achieved in most patients with NIDDM because they are usually overweight and resistant to dietary controls. In fact, their excess weight is a major factor in precipitating the overt diabetes, especially in those predisposed by heredity. 3 In Rochester, Minnesota,4 59% of cases of diabetes were diagnosed among men and women with a body mass index (BMI) greater than 28.3 kg/M2, and in the Nurses' Health Study,5 61% of the diabetic women aged 30 to 64 had BMIs of 29 kg/M2 or more. Among these obese women, 94% of NIDDM prevalence was attributed to obesity.
Over the last 11 years, we have treated 515 severely obese patients, most ofwhom demonstrated abnormalities ofglucose and insulin metabolism, with surgery to control their weight. The operation, the Greenville gastric bypass (GGB) , limits intake by the fashioning of a small gastric pouch, delays gastric emptying with a small outlet, and bypasses the foregut with a Roux-en-Y anastomosis. The procedure is effective: in addition to inducing long-term weight loss, it helps in the control of hypertension and returns many of those handicapped by severe obesity to functional effectiveness.
Four years ago, we6 reported that the GGB operation restored some ofthe severely obese patients with NIDDM to euglycemia. This article is a report of our continued studies of the effect of the procedure on the glucose and insulin metabolism of these patients.
Materials and Methods: Clinical Studies
From February 1, 1980 to August 1, 1991, 515 consecutive morbidly obese patients (each exceeding their ideal body weight by 100 pounds or more) underwent the standardized GGB.
Demographic Data
The 515 patients included 359 white and 79 black women as well as 64 white and 13 black men. Of the group, 360 were married, 44 were divorced, 83 were single, 18 were separated, and 10 were widows. The job status survey showed that 324 were employed and 191 were not.
Diabetic Status
The state of the diabetes was defined in accordance with the standards of the National Diabetes Data Group (Table 1) 
Patient Selection and Eligibility
Patients of either sex were considered eligible for inclusion if they met the following criteria: (1) ages between 18 and 65 years (although an exception was made for a girl of 16); (2) severely obese, in other words, they exceeded their ideal body weight as given in the midpoint of the 1983 Metropolitan Life Insurance Tables by 100 pounds or more; (3) suitable operative risks after evaluation of their physical and emotional status; (4) capable of understanding the operation and the postoperative consequences and instructions; (5) agreement to long-term follow-up; (6) informed consent; and (7) funding for the surgery and the various required tests. Patients were excluded during the course of the evaluation if they (1) were not sufficiently obese; (2) had a history ofalcohol or substance abuse within the last 5 years; (3) had a history of severe psychiatric dysfunction, especially evidence of suicidal attempts, serious depression, or paranoia; and (4) had inappropriate expectations of the surgery in spite of counseling, and met strong continued opposition by other family members.
Preoperative Evaluation
We have continued to decrease the intensity ofour preoperative evaluation over the 11 years of the study with the elimination of those tests, such as levels of trace elements, that have produced too few significant abnormal levels to warrant the effort and the expense. Our current approach includes the following examinations: tion is gently continued behind the esophagus and cardia. The channel is complete when the finger is brought out, not at the right side of the esophagus, but just below the first arcade of branches from the left gastric artery about 2.3 to 3.0 cm below the cardia. A large Malecot catheter, from which the bulbous end has been cut, is used to pull one limb of the TA-90 four-staple-line device through the passage. A proximal pouch measuring 4 cm in width and 1.5 cm in height is then separated from the stomach by firing the staples. A figure-of-eight 3-0 polypropylene suture is placed at the end of the staple line to close the ends securely and to serve as guy sutures during the anastomosis. The stomach is then divided by cutting between the two paired lines of staples, and both staple lines are then oversewn with 3-0 absorbable suture. (The division of the stomach is new: the partitioning of the stomachs of the 515 patients reported in this report was accomplished with the stapler alone. The high incidence of staple line failure and the success ofgastric division for revisions of failed gastric bypasses has convinced us that division is the better approach and, accordingly, on October 25, 1991, we changed our protocol, altering our procedure for the first time in over 11 years.) The jejunum is divided at the apex of the first or second arcade (depending on which provides a longer Roux-en-Y limb), about 40 cm from the ligament of Treitz, with a cutting stapling device, and the distal end is then sutured to the gastric pouch.
The anastomosis is sewn to fit snugly around a 0.8-cm Salem sump tube in two layers with continuous 3-0 polyVOl. 2 15 * NO. 6 propylene suture. The entero-enterostomy is then completed by joining the proximal jejunum end-to-side to the distal jejunum with the cutting and the TA 55 staplers. It is important to fasten the Roux loop to the mesocolon with several sutures to prevent an internal hernia and to oversew the bleeders inside the entero-enterostomy before closing the intestine. The abdomen is closed with a running, double-stranded, 1-absorbable monofilament suture. The skin is closed with skin staples without a subcutaneous suture line. The operation usually can be performed in 1 to 2 hours; blood loss rarely exceeds 300 mL.
Postoperative Care
In general, the postoperative care of bariatric patients resembles that after standard abdominal surgery in highrisk patients and therefore will not be described in detail except to emphasize the need for prophylactic antibiotics, careful monitoring ofvital signs, fluid balance, and glucose metabolism, and the requirement for appropriate furniture and equipment to manage these massive patients. The first 24 hours are particularly critical because of the serious consequences of a leak or intra-abdominal infection in the morbidly obese. If the pulse remains over 120 for more than 4 hours without an evident reason, if there is a rise in body temperature to over 39 C (102 F), or if the patient looks ill in spite of normal signs, prompt emergency exploration and the addition of other antibiotics may be needed. Examinations with the swallow of radiopaque materials to demonstrate leaks are not reliable and should not be used as a reason for failure to re-explore. Neglect of a perforation or intra-abdominal infection is associated with a high mortality rate. Patients generally spend the first night in the critical care unit or a monitored ward bed for close observation and then spend the rest of their hospital stay (usually a total of 5 to 6 days) on surgical wards. Nasogastric tubes are usually removed on the third day. When the patients pass flatus, they are begun on water at 1 oz/hour, followed by the addition of a highprotein fluid preparation, half-strength on the next day, and full-strength on the day of discharge. Patients are maintained on the full-strength preparation for 2 weeks and then advanced slowly to a regular diet.
Follow-up
Follow-up has been rigorous. Return visits are timed weekly for the first month, then every third month for a year, and for every 6 months for continuing follow-up. Over the 11 years we have maintained follow-up with all but 17 of the 515 patients (96.7%).
Biopsies for Studies ofInsulin Action
A 10-mL sample of venous blood and biopsies of fat, liver, muscle, and pancreas were obtained in several cohorts of patients in accordance with protocols approved by the institutional review boards of the East Carolina University School of Medicine and the Pitt County Memorial Hospital. The blood and cold steel biopsies were obtained as soon as the abdomen was opened and after a thorough exploration showed no contraindications to the biopsies. The specimens of fat, measuring about 3 X 3 X 1 cm, were removed from (1) subcutaneous fat, (2) properitoneal fat, and (3) omental fat. The liver samples, measuring 2 X 2 X 3 cm, were usually obtained from the leading edge ofthe left lobe, but sometimes from the right, depending on the exposure. Hemostasis and closure of the defect were obtained with serosal running sutures of 3-0 absorbable braided suture. The strips ofrectus muscle, measuring 1 X 0.5 X 3 cm were obtained by blunt elevation of the fibers from the muscle bed, clamping these into a specially designed clamp to maintain their stretch, and transecting the fibers proximally and distally to the clamp. Pancreatic biopsies have only been done recently. These samples, measuring 0.3 X 0.3 X 0.3 cm, were removed from the inferior side of the body of the pancreas after incising the peritoneum at the junction of the mesocolon and the posterior peritoneum. After the removal of the specimen, the pancreatic capsule was closed with one suture of 3-0 monofilament absorbable suture and covered, with the peritoneum closed with the same material. To our knowledge, and after continuing rigorous review of our records, we know of no instance in which any of the biopsies produced a complication.
Our methods for isolating insulin-responsive human hepatocytes,'°human skeletal muscle," and human adipocytes'2 have been previously described. Results from these in vitro studies have been recently reviewed by Caro and his associates. 13
Results

Control of Weight
Weight reduction in these patients has been dramatic and well maintained over the 132 months of follow-up. Table 2 presents the weight loss of all 515 patients who have undergone the GGB in time intervals after surgery, in mean weight in pounds, in mean percentage of excess weight loss, and in mean percentage of ideal body weight as indicated by the 1983 Metropolitan Life Insurance Tables. If severe obesity is defined as 100 pounds over ideal weight, 89% ofthe patients are no longer "morbidly" obese within 2 years. Figure 2 demonstrates that there is some weight gain between 24 and 132 months (from a mean of 183 to 221 pounds or 20.8%), reflecting those 49 (9.5%) patients who had staple line breakdowns and others who learned to "outeat" their pouches with high-calorie liquids or continued snacking.
"Reversal" ofDiabetes Table 3 shows that of the 500 severely obese patients who completed the oral glucose tolerance test and un- and glycosylated hemoglobin in a cohort of 52 consecutive severely obese patients with NIDDM. The 28 NIDDM patients who did not go into complete remission and the two glucose-impaired patients who progressed to NIDDM were examined in detail. Factors that may be associated with these failures include four patients with staple line breakdowns, two patients with gastric outlet dilatation, eight patients with rising weight that may be indicative of dietary indiscretion or undiagnosed staple breakdown, one patient with Hodgkin's disease, and one patient with severe arthritis and steroidassociated weight gain, leaving 15 patients without discernible risk factors.
Patients with good glucose control were about 8 years younger (41.9 ± 1.9 versus 49.6 ± 2.8 years), and their diabetes was of far shorter duration (1.75 ± 0.69 versus 8.79 ± 2.8 years) than those patients who had poor glucose control.
The level ofpreoperative fasting glucose also determines the degree of postoperative control, as shown in Figure 3 . The patients with the higher postoperative glucose values experienced greater drops in fasting blood sugar than their The improvements in insulin levels, glycosylated hemoglobin (HbA lc), and glucose levels do not parallel each other consistently. In contrast to the insulin levels that fall predictably after gastric bypass (Fig. 4) , the levels of HbA c (Fig. 5 ) and fasting blood sugar (Fig. 6 ) on the same group of patients show a much wider scatter. The reasons for this unexpected difference in the behavior of these diabetic indices is not clear.
The glucose tolerance curves and fasting insulin levels were compared in 1 7 lean controls, 85 nondiabetic obese, 39 glucose-impaired obese, 29 NIDDM obese with fasting blood sugar < 140 mg/dL, and 25 NIDDM obese with fasting blood sugar > 140 mg/dL. The data, shown in Figures 7 and 8 , suggest that insulin production continues to rise with increasing insulin resistance until, finally, the beta cells fail to reach effective insulin production on demand and, as a consequence, blood glucose levels rise out of control. In short, the progression of the two diseases, NIDDM and obesity, parallel each other. The diabetes, these data suggest, appears to be due to ever-increasing insulin resistance and the eventual failure of the pancreas to meet the ever higher demand for insulin production. In a way, type II diabetes mellitus, at its most severe and terminal point, resembles type 1 diabetes, with inadequate insulin production.
Control ofHypertension
The GGB favorably affected hypertension. Of the 515 patients, 301 (58.4%) were hypertensive before the operation and, ofthese, 169 (56.1%) were on antihypertensive medication. After the GGB, 96 of the 301 (31.9%) remained hypertensive, and 88 (29.2%) were maintained on antihypertensive therapy.
Perioperative and Late Complications
The perioperative mortality rate was 1.2%, in other words, six of 515 patients died within 30 days after their operation or during their first hospitalization, a low rate in view of the fact that 47 (9.1%) of these patients in the series were, in addition to being severely obese, also in cardiopulmonary failure before surgery. As demonstrated in Table 5 , 83% ofthe perioperative deaths were of sepsis.
There were 17 late deaths, of which 7 (41.1%) were related to emotional problems: three were suicides, two died of cirrhosis due to alcohol abuse, and two died of self-imposed malnutrition. Another three, those from motor vehicle fatalities, are suspect because depression or other emotional factors are frequently involved in car crashes. The investigating authorities, however, have cited all three as accidents and we have been unable to obtain any further details. The death of acquired immune deficiency syndrome was caused by an infection transmitted from a transfusion during a plastic surgery procedure at another hospital; the unknown death appears to have been a result of an arrhythmia.
Perioperative complications are listed in Table 6 . Wound problems and infections are the most common cause of prolonged hospitalization in the severely obese, probably related to the high incidence of NIDDM. Table  7 lists those late complications that occur at a rate of 1% or greater. The most common problems seen over the 11 years of follow-up include depression and other psychiatric problems; vitamin and iron deficiencies; incisional hernias; cholecystitis; and technical problems associated with the operation such as staple line failures, anastomotic dilatations or stenoses, and bowel obstructions due to adhesions. 
MONTHS POST-OPERATIVE Discussion
One of the main goals in the management of NIDDM is euglycemia through weight control. Unfortunately, most patients with NIDDM are overweight, and further, NIDDM is especially common in patients who are severely obese, in other words, who exceed their ideal body weight by 100 pounds or more. Diets do not work in these massive individuals, and the general course of their illness is a pattern of ever-increasing weight, worsening diabetes, and progression of diabetic complications. Our data suggest that surgical intervention with the gastric bypass offers 19- FIG. 5. Changes in Hbl Ac after gastric bypass. There is considerably greater scatter than is seen in the insulin levels. Patients, however, usually seek surgical intervention because of limitations in function rather than for health indications.'6 Fat people are frequently objects of public scorn and malicious ridicule. Employers are often reluctant to hire them because they are considered unattractive, have high rates of absenteeism due to illness, fall asleep on the job, and are thought to have a higher accident rate in factories because oftheir clumsiness and loose clothing. Obesity limits the availability of educational opportunities and a chance to find a spouse. Finally, our patients frequently mention their inabilities to meet their parental and other social roles: their children and other family members are ashamed to be seen with them at school, at athletic events, and in social situations. In short, the environment ofthe severely obese is neither happy nor filled with opportunities. Kral et al.'7 summarized their problems well when they concluded that the severely obese are handicapped by every measure: physically, emotionally, economically, and socially. Morbid obesity is indeed a serious disease; if diabetes is present as well, it becomes even more dangerous.
The estimated annual mortality rate in sudden death among the severely obese is 65/100,000, in other words, 40 times higher than expected in the general population." An American Cancer Society study"8 disclosed deaths from all causes to be 50% higher among men and women who were merely 30% to 40% above normal weight. Mor have a 12-fold increase in mortality rate.'9 Bray's20 data, shown in Figure 9 , graphically demonstrate the relationship of mortality to the body mass index (kg/M2).
Second, the National Institutes of Health panel agreed that surgery has become the therapy ofchoice. According to the summary of the conference, more than 12 million Americans are severely overweight, and 4 and either reverse or avoid many of the health and social problems associated with severe obesity. These operations are, however, not the only bariatric operations that ameliorate or reverse diabetes. Most operations reported to induce weight loss, including the intestinal bypasses, gastric bypasses, and gastroplasties, have shown this effect. It is our impression that the gastric bypass, with its bypass of the hormonal axis of the foregut and greater weight loss, does this more effectively than the gastroplasties, but our evidence for this remains fragmentary.
Conclusion
The gastric bypass operation is an effective therapy for the treatment of NIDDM in the severely obese. The operation can be done with acceptable morbidity and mortality rates, and the effects ofthe procedure are well maintained over 11 years of observation. The procedure, with the modification that divides rather than staples the stomach, should now be considered for obese patients who are 
